Biotechnology company Amgen, facing pressure from activist investor Daniel Loeb, Tuesday unveiled plans to implement deeper job cuts, lift shareholder payouts and increase revenues to more than $20 billion in 2015.
Business
Oct 28, 2014
0
0
Tax credits helped biotech giant Amgen report first-quarter earnings that beat Wall Street's expectations, but sales growth disappointed investors.
Business
Apr 23, 2013
0
0
(AP) — Amgen Inc.'s second-quarter net income rose 8 percent as the world's largest biotech company benefited from higher sales for its top-selling drugs and a gain from selling its share of an experimental medicine.
Business
Jul 27, 2012
0
0
